223 related articles for article (PubMed ID: 16942024)
1. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors.
Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W
J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024
[TBL] [Abstract][Full Text] [Related]
2. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.
Barth RF; Yang W; Wu G; Swindall M; Byun Y; Narayanasamy S; Tjarks W; Tordoff K; Moeschberger ML; Eriksson S; Binns PJ; Riley KJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17493-7. PubMed ID: 18981415
[TBL] [Abstract][Full Text] [Related]
5. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer.
Narayanasamy S; Thirumamagal BT; Johnsamuel J; Byun Y; Al-Madhoun AS; Usova E; Cosquer GY; Yan J; Bandyopadhyaya AK; Tiwari R; Eriksson S; Tjarks W
Bioorg Med Chem; 2006 Oct; 14(20):6886-99. PubMed ID: 16831554
[TBL] [Abstract][Full Text] [Related]
6. Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.
Sjuvarsson E; Damaraju VL; Mowles D; Sawyer MB; Tiwari R; Agarwal HK; Khalil A; Hasabelnaby S; Goudah A; Nakkula RJ; Barth RF; Cass CE; Eriksson S; Tjarks W
J Pharmacol Exp Ther; 2013 Nov; 347(2):388-97. PubMed ID: 24006340
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
8. Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation.
Cai J; Soloway AH; Barth RF; Adams DM; Hariharan JR; Wyzlic IM; Radcliffe K
J Med Chem; 1997 Nov; 40(24):3887-96. PubMed ID: 9397169
[TBL] [Abstract][Full Text] [Related]
9. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors.
Zhuo JC; Cai J; Soloway AH; Barth RF; Adams DM; Ji W; Tjarks W
J Med Chem; 1999 Apr; 42(7):1282-92. PubMed ID: 10197971
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of a boronated nitroimidazole for boron neutron capture therapy.
Swenson DH; Laster BH; Metzger RL
J Med Chem; 1996 Mar; 39(7):1540-4. PubMed ID: 8691485
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.
Barth RF; Yang W; Nakkula RJ; Byun Y; Tjarks W; Wu LC; Binns PJ; Riley KJ
Appl Radiat Isot; 2015 Dec; 106():251-5. PubMed ID: 26282567
[TBL] [Abstract][Full Text] [Related]
13. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.
Agarwal HK; McElroy CA; Sjuvarsson E; Eriksson S; Darby MV; Tjarks W
Eur J Med Chem; 2013 Feb; 60():456-68. PubMed ID: 23318906
[TBL] [Abstract][Full Text] [Related]
15. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy.
Al-Madhoun AS; Johnsamuel J; Barth RF; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6280-6. PubMed ID: 15342416
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
[TBL] [Abstract][Full Text] [Related]
20. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
